首页> 外文期刊>Acta microbiologica et immunologica Hungarica: A quarterly of the Hungarian Academy of Sciences >Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice
【24h】

Immune responses against chimeric DNA and protein vaccines composed of plpEN-OmpH and PlpEC-OmpH from Pasteurella multocida A:3 in mice

机译:对多杀巴斯德氏菌A:3的plpEN-OmpH和PlpEC-OmpH组成的嵌合DNA和蛋白质疫苗的免疫反应

获取原文
获取原文并翻译 | 示例
       

摘要

Pasteurella multocida is a pathogenic bacterium causing many diseases that are of significant economic importance to livestock industries. Outer membrane protein H (ompH) gene and two fragments of Pasteurella lipoprotein E (plpE) gene, namely plpEN and plpEC, were cloned from P. multocida A:3. Three DNA vaccine formulations, namely pCMV-ompH, pCMV-plpEN-ompH and pCMV-plpEC-ompH and two protein-based prototype vaccines, alum adjuvanted PlpEN-OmpH and PlpEC-OmpH, were generated. Antibody levels were induced in mice vaccinated with chimeric DNA or protein vaccines. A significant (p < 0.05) increase in serum IFN-g titer was obtained by vaccination with 100 μg of pCMV-ompH, pCMV-plpEC-ompH and PlpEC-OmpH. DNA vaccines did not provide protection upon intraperitoneal challenge with 10 LD50 of live P. multocida A:3. However, 40% protection was conferred by 100 μg of PlpEC-OmpH which was not statistically significant. These results showed that plpEN-ompH and plpEC-ompH chimeric DNA vaccines and alum adjuvanted PlpEN-OmpH or PlpEC-OmpH protein vaccines were immunogenic but not protective against P. multocida A:3 in mice. Prime-boost strategies, i.e. priming with DNA vaccines and boost with protein formulations or different adjuvants can be utilized to obtain significant protection.
机译:多杀性巴氏杆菌是引起许多疾病的致病细菌,这些疾病对畜牧业具有重要的经济意义。从多杀性疟原虫A:3中克隆了外膜蛋白H(ompH)基因和巴斯德氏杆菌脂蛋白E(plpE)基因的两个片段,即plpEN和plpEC。产生了三种DNA疫苗制剂,即pCMV-ompH,pCMV-plpEN-ompH和pCMV-plpEC-ompH,以及两种基于蛋白质的原型疫苗,明矾佐剂PlpEN-OmpH和PlpEC-OmpH。在用嵌合DNA或蛋白质疫苗接种的小鼠中诱导抗体水平。通过接种100μgpCMV-ompH,pCMV-plpEC-ompH和PlpEC-OmpH疫苗,血清IFN-g滴度显着提高(p <0.05)。 DNA疫苗在用10 LD50的多杀性活疟原虫A:3腹膜内攻击后不能提供保护。但是,100μgPlpEC-OmpH赋予40%的保护作用,这在统计学上并不显着。这些结果表明,plpEN-ompH和plpEC-ompH嵌合DNA疫苗以及明矾佐剂的PlpEN-OmpH或PlpEC-OmpH蛋白疫苗具有免疫原性,但对小鼠多杀疟原虫A:3没有保护作用。初免-加强策略,即DNA疫苗的初免和蛋白制剂或不同佐剂的加强,可用于获得显着的保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号